Clinical Trials · NCT00631527
Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- M.D. Anderson Cancer Center
- Enrollment
- 19
- Start date
- Feb 2008
- Locations
- 1 site, United States
- Primary endpoint
- Maximum Tolerated Dose (MTD) as defined by Dose Limiting Toxicity (DLT)